-5.6 | | FBXW12 | 'Snai1 knockout' vs 'wild type' | genotype | Ampliseq transcriptomic array of REF seq. genes in Snai1 knock out triple negative breast cancer cells |
-4.7 | | FBXW12 | 'breast carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
4.3 | | FBXW12 | 'induced pluripotent stem cell' vs 'fibroblast of dermis' in 'Klinefelter's syndrome' | cell type, disease | Klinefelter syndrome derived hiPSCs show similar XCI behavior as female hPSCs |
-3.8 | | FBXW12 | 'colorectal carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-3.5 | | FBXW12 | 'induced MCT8 mutation' vs 'wild type genotype' in 'derived neural cell; T3; 100 nanomolar' | cell type, compound, genotype | RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells |
-3.4 | | FBXW12 | 'pancreatic adenocarcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-3.2 | | FBXW12 | 'non-small cell lung carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
3.2 | | FBXW12 | 'induced pluripotent stem cell' vs 'fibroblast of dermis' in 'normal' | cell type, disease | Klinefelter syndrome derived hiPSCs show similar XCI behavior as female hPSCs |
-3.2 | | FBXW12 | 'T3; 100 nanomolar' vs 'none' in 'derived neural cell; induced MCT8 mutation' | cell type, compound, genotype | RNA-seq analysis of MCT8-deficient and healthy control brain microvascular endothelial cells (BMECs) and neural cells |
2.8 | | FBXW12 | '12 hour' vs '0 hour' in 'MCF-10A' | cell line, time | Knock-in of PIK3CA-H1047R into MCF-10A |
-2.7 | | FBXW12 | 'COVID-19' vs 'normal' in 'lung' | disease, organism part | Lung and colon transcriptome profiling of fatal COVID-19 cases |
2.7 | | FBXW12 | 'Human gammaherpesvirus 4' at '8 day' vs 'none' at '0 day' | infect, time | Infection of naïve primary human B-lymphocytes with Epstein-Barr virus (EBV) – time course transcriptomic analysis in the pre-latent phase of viral infection |
-2.4 | | FBXW12 | ' neural stem cell' vs 'induced pluripotent stem cell' in 'normal' | cell type, disease | Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks |
-2.4 | | FBXW12 | 'hepatobiliary carcinoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
2.4 | | FBXW12 | 'induced pluripotent stem cell' vs 'cardiac muscle cell' | cell type | Gene expression profiling by RNA-seq of human iPSC and iPSC-derived cardiomyocytes from an Yoruban individual (NA19101) |
-2.4 | | FBXW12 | 'neoplasm' vs 'normal tissue adjacent to neoplasm' | sampling site | Global gene expression profiles of 10 gastric cancer (GC) samples and 10 gastric normal adjacent tissue (gNAT) samples |
-2.1 | | FBXW12 | 'glioblastoma' vs 'normal' | block, disease | RNA-seq of blood platelets from six tumor types and healthy donors |
-2.1 | | FBXW12 | 'familial hemophagocytic lymphohistiocytosis 5' vs 'normal' | disease | RNAseq on PBMC of three patients with Familial Hemophagocytic Lymphohistiocytosis Type 5 (FHL5) and three age and sex-matched controls |
-2.1 | | FBXW12 | '3 h DRB 8 min 4sU' vs 'untreated' | treatment | 4sUDRB-seq: measuring transcription elongation and initiation genomewide |
-2.1 | | FBXW12 | 'valproic acid; 15 millimolar' vs 'control' at '2 day' | compound, sampling time point | RNA-seq of Primary Human Hepatocytes (PHH) exposed to Valproic Acid (VPA) for 3 days daily and 3 days daily exposure followed by 3 days washout. |
1.9 | | FBXW12 | 'progenitor cell of endocrine pancreas' vs 'definitive endoderm cell' in 'GATA6 R456C/+; Patient A" | cell line, cell type, genotype, individual | RNA-seq of definitive endoderm and pancreatic progenitor cells derived in vitro from human pluripotent stem cells in order to study the role of transcription factor GATA6 in human pancreas development |
1.8 | | FBXW12 | 'TIGAR knockdown' vs 'wild type' | phenotype | RNA-seq of human cancer cell line OVCA420* following TIGAR knockdown with shRNA |
1.8 | | FBXW12 | 'PLX4720; 1 micromolar' vs 'none' | compound | RNA-seq of the human melanoma cell-line A375P treated with the BRAF inhibitor PLX4720 and a DMSO control |
1.7 | | FBXW12 | 'colorectal cancer metastatic in the liver' vs 'normal' | biopsy site | RNA-seq of 54 samples (normal colon, primary tumor, and liver metastases) from 18 colorectal cancer patients |
1.7 | | FBXW12 | 'doxycycline-mediated expression of dominant-negative FOS' vs 'wild type' | phenotype | Transcription profiling of oesophageal adenocarcinoma by RNA-seq |
-1.6 | | FBXW12 | 'human intestinal organoids derived from H9 stem cells' vs 'Undifferentiated H9 Stem Cells' | cell type | Transcriptional Profiling of human pluripotent stem cells and and derived tissues |
1.6 | | FBXW12 | 'Human betacoronavirus 2c England-Qatar/2012; 24 hour' vs 'mock; 18 hour' | infect, time | Transcription profiling of human bronchial epithelial cell line Calu-3 2B4 infected with Human Coronavirus MERS-CoV-London |
1.5 | | FBXW12 | 'overexpression of Halo-RelA' vs 'control' | phenotype | Transcription profiling by high throughput sequencing of HEK293 cells expressing Halo-RelA, Halo-NFkB1, or Halo tag alone |
1.5 | | FBXW12 | 'human cytomegalovirus (Towne strain)' vs 'none' | infect | RNAseq of proneural glioblastoma stem-like cells 72 hours after infection with human cytomegalovirus (CMV) Towne strain |
-1.5 | | FBXW12 | 'definitive endoderm cell; 72 hour' vs 'embryonic stem cell; 0 hour' | cell type, time | RNA-seq of definitive endoderm differentiation of human embryonic stem cells in early G1 phase of the cell cycle |
-1.5 | | FBXW12 | ' neural stem cell' vs 'induced pluripotent stem cell' in 'Ataxia-telangiectasia' | cell type, disease | Human iPSC-Derived Cerebellar Neurons from a Patient with Ataxia-Telangiectasia Reveal Disrupted Gene Regulatory Networks |
-1.5 | | FBXW12 | 'squamous cell carcinoma' vs 'normal' | block, disease | RNA-seq of a panel of non-melanoma skin cancer lesions |
1.4 | | FBXW12 | 'differentiated; hAKPC-P' vs 're-differentiated; hIPod' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
-1.4 | | FBXW12 | 'ulcerative colitis' vs 'normal' | disease | PSC-IBD mucosal biology |
1.3 | | FBXW12 | 'Zaire ebolavirus lacking the mucin domain of GP' vs 'mock' at '18 hour' | infect, time | Human U937 cell transcriptome response to Zaire Ebola virus wild-type in the delta-VP30 background and delta-mucin virus |
1.3 | | FBXW12 | '501Mel; shBRG1 knockdown' vs '501Mel; control' | cell line, phenotype | BRG1 recruitment by transcription factors MITF and SOX10 defines a specific configuration of regulatory elements in the melanocyte lineage (RNA-seq) |
-1.3 | | FBXW12 | 'definitive endoderm differentiated from H9 stem cells' vs 'Undifferentiated H9 Stem Cells' | cell type | Transcriptional Profiling of human pluripotent stem cells and and derived tissues |
1.2 | | FBXW12 | 'differentiated; hAKPC-P' vs 'undifferentiated; hIPod' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
1.2 | | FBXW12 | 'differentiated; hAKPC-P' vs 'undifferentiated; hAKPC-P' | cell type, phenotype | Differentiation of human amniotic fluid kidney progenitor cells into podocytes and comparison with human conditionally immortalized podocytes |
-1.2 | | FBXW12 | 'embryonic stem cell differentiating toward definitive endoderm; 60 hour' vs 'embryonic stem cell; 0 hour' | cell type, time | RNA-seq of definitive endoderm differentiation of human embryonic stem cells in early G1 phase of the cell cycle |
-1.2 | | FBXW12 | 'resembling native pluripotent cell; 3iL inducer' vs 'wild type; none' | phenotype, treatment | RNA-Seq of 3iL human embryonic stem cells with an induced expression profile that more closely resembles native pluripotent cells and uninduced controls |
1.2 | | FBXW12 | 'KLF17 overexpression' vs 'wild type phenotype' at '2 day' | phenotype, time | RNA-seq of hESCs overexpressing inducible KLF17 versus uninduced controls. |
1.1 | | FBXW12 | 'CRISPR-Cas9 induced GNRH1 reporter; 27 day' vs 'wild type genotype; 20 day' | genotype, stimulus, time | RNA-Seq of GNRH1 neurons differentiated from human pluripotent stem cells |
-1.1 | | FBXW12 | 'sebaceous of Jadassohn nevus' vs 'normal' | block, disease | RNA-seq of a panel of non-melanoma skin cancer lesions |
1.1 | | FBXW12 | 'tumor tissue' vs 'non-malignant tissue' | sampling site | RNA-seq of 199 non-small cell lung carcinoma patients and 19 paired normal lung tissues |
1 | | FBXW12 | 'blood alcohol content 0.08%' vs 'control' in 'time point 3' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1 | | FBXW12 | 'blood alcohol content 0.04%declining' vs 'control' in 'time point 4' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1 | | FBXW12 | 'blood alcohol content 0.04%rising' vs 'control' in 'time point 2' | sampling time point, treatment | Microarray characterization of gene expression changes in blood during acute ethanol exposure |
1 | | FBXW12 | 'cultured skin substitute; 28 day' vs 'skin; 0 day' | organism part, time | Transcription profiling by array of human grafted engineered skin substitutes |
1 | | FBXW12 | 'NSAID-exacerbated respiratory disease' vs 'normal' | disease | Total RNAseq of human healthy control inferior turbinate and glucocorticoid-treated, NSAID-exacerbated respiratory disease (N-ERD) nasal polyp nasal brushings |
1 | | FBXW12 | 'Zaire ebolavirus lacking the VP30 gene' vs 'mock' at '18 hour' | infect, time | Human U937 cell transcriptome response to Zaire Ebola virus wild-type in the delta-VP30 background and delta-mucin virus |
-1 | | FBXW12 | 'embryonic stem cell differentiating toward definitive endoderm; 36 hour' vs 'embryonic stem cell; 0 hour' | cell type, time | RNA-seq of definitive endoderm differentiation of human embryonic stem cells in early G1 phase of the cell cycle |
